{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:49:17Z","timestamp":1776235757132,"version":"3.50.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Multidrug-resistant organisms (MDROs) pose a severe threat to neutropenic patients with compromised immunity, leading to poor outcomes and increased healthcare burdens. This study aimed to develop and validate a prediction model for MDRO infections in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 391 neutropenic patients (206 in training cohort, 185 in validation cohort) admitted to Ningbo Medical Center Lihuili Hospital, from January 2023 to December 2024 were enrolled. Demographic, clinical, and outcome data were collected. The least absolute shrinkage and selection operator (LASSO) regression and multivariate logistic regression analyses were used to identify independent risk factors, and a nomogram was constructed for prediction. Model performance was evaluated via receiver operating characteristic (ROC),calibration curves and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MDRO infection occurred in 14.1% of patients, associated with longer hospital stays, higher costs, and increased mortality. Independent risk factors included comorbid cardiac disease (OR\u00a0=\u00a013.500, 95%CI: 2.484-73.384, P\u00a0=\u00a00.003), ECOG score\u22652 (OR\u00a0=\u00a03.210, 95%CI: 1.114-9.255, P\u00a0=\u00a00.031), neutropenia duration\u22657 days (OR\u00a0=\u00a04.028, 95%CI: 1.399-11.600, P\u00a0=\u00a00.010), and broad-spectrum antibiotic use in 3 months prior (OR\u00a0=\u00a013.053, 95%CI: 2.419-70.441, P\u00a0=\u00a00.003). The nomogram demonstrated good discriminative ability, with an area under the ROC curve of 0.874 in the training cohort and 0.764 in the validation cohort. Calibration curves confirmed favorable prediction accuracy and the DCA showed good clinical applicability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study identifies key risk factors and provides a practical predictive tool for early identification of high-risk patients, enabling targeted interventions to reduce MDRO infections, improve patient outcomes, and alleviate healthcare burdens.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1805777","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:46:48Z","timestamp":1776232008000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of risk factors and construction of a prediction model for multidrug-resistant organism infections in neutropenic patients"],"prefix":"10.3389","volume":"16","author":[{"given":"Dian","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Hematology, Ningbo Medical Center Lihuili Hospital","place":["Ningbo, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo Medical Center Lihuili Hospital","place":["Ningbo, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxiu","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo Medical Center Lihuili Hospital","place":["Ningbo, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo Medical Center Lihuili Hospital","place":["Ningbo, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingrong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo Medical Center Lihuili Hospital","place":["Ningbo, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3324\/haematol.2014.103770","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"key":"B2","doi-asserted-by":"publisher","first-page":"i6","DOI":"10.1093\/jac\/dky530","article-title":"Impact of antimicrobial therapy on the gut microbiome","volume":"74","author":"Bhalodi","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3760\/cma.j.issn.0253-2727.2020.12.001","article-title":"Chinese guidelines for the clinical application of antibacterial drugs for agranulocytosis with fever (2020)","volume":"41","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"B4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/ejh.14157","article-title":"Screening for multidrug-resistant organisms in high-risk hospitalized patients with hematologic diseases","volume":"112","author":"Delanote","year":"2024","journal-title":"Eur. J. Haematol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/bmt.2016.234","article-title":"Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation","volume":"52","author":"Forcina","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2024.101352","article-title":"Exploring the prevalence, predictors, and impact of bacterial infections to guide empiric antimicrobial decisions in cirrhosis (EPIC-AD)","volume":"14","author":"Garg","year":"2024","journal-title":"J. Clin. Exp. Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/bmt.2014.231","article-title":"Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy","volume":"50","author":"Girmenia","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-014-0435-z","article-title":"Inflammation and cardiovascular disease: from pathogenesis to therapeutic target","volume":"16","author":"Golia","year":"2014","journal-title":"Curr. Atheroscler Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1001\/jama.2024.2759","article-title":"Reducing hospitalizations and multidrug-resistant organisms via regional decolonization in hospitals and nursing homes","volume":"331","author":"Gussin","year":"2024","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1086\/383050","article-title":"Management of fever in neutropenic patients with different risks of complications","volume":"39","author":"Klastersky","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kuderer","year":"2006","journal-title":"Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/s0140-6736(22)00087-3","article-title":"The overlooked pandemic of antimicrobial resistance","volume":"399","author":"Laxminarayan","year":"2022","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13756-020-00728-3","article-title":"Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China","volume":"9","author":"Li","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"B15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.16555","article-title":"Effectiveness of a multicomponent intervention to reduce multidrug-resistant organisms in nursing homes: a cluster randomized clinical trial","volume":"4","author":"Mody","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"B17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am. J. Clin. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/cncr.31045","article-title":"Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia","volume":"124","author":"Scheich","year":"2018","journal-title":"Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227139","article-title":"Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: systematic review and meta-analysis","volume":"15","author":"Serra-Burriel","year":"2020","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/archinte.1975.00330050089015","article-title":"Clinical presentation of infection in granulocytopenic patients","volume":"135","author":"Sickles","year":"1975","journal-title":"Arch. Intern. Med."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14236","article-title":"Approach to febrile neutropenia in patients undergoing treatments for hematologic Malignancies","volume":"26","author":"Stohs","year":"2024","journal-title":"Transpl Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1093\/cid\/ciy658","article-title":"Incidence, risk factors, microbiology and outcomes of pre-engraftment bloodstream infection after haploidentical hematopoietic stem cell transplantation and comparison with HLA-identical sibling transplantation","volume":"67","author":"Yan","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110230","article-title":"Advances in the relationship between coronavirus infection and cardiovascular diseases","volume":"127","author":"Zhao","year":"2020","journal-title":"Biomed. Pharmacother."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1805777\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:46:49Z","timestamp":1776232009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1805777\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":23,"alternative-id":["10.3389\/fcimb.2026.1805777"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1805777","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"1805777"}}